IHME logo
Loading...

Damian Santomauro

Affiliate Assistant Professor

Dr. Damian Santomauro is an Affiliate Assistant Professor of Health Metrics Sciences at the Institute for Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. He is a research fellow for the Psychiatric Epidemiology and Burden of Disease (PEABOD) Research Group based at the Queensland Centre for Mental Health Research (QCMHR), Queensland, Australia. He is also an affiliate assistant professor at the Institute for Health Metrics and Evaluation (IHME), University of Washington, for his work on the Global Burden of Disease Study where he is responsible for the epidemiological modeling of autism spectrum disorders (ASD), fetal alcohol syndrome, and alcohol dependence. Damian’s PhD investigated emotion regulation in adolescents and young adults with ASD. This project involved managing the first randomized controlled trial of a group cognitive behavioral intervention targeting depression in adolescents with ASD ever conducted. Damian has a keen interest in statistics and research methodology and currently acts as PEABOD’s resident statistician.

Publications

Showing 1 - 5 of 29 results
Santomauro DF, Vos T, Whiteford HA, et al. Service coverage for major depressive disorder: estimated rates of minimally adequate treatment for 204 countries and territories in 2021. The Lancet Psychiatry. 19 November 2024. doi: 10.1016/S2215-0366(24)00317-1.
Wu Y, Wulf Hanson S, Culbreth G, et al. Assessing the impact of health-care access on the severity of low back pain by country: a case study within the GBD framework. The Lancet Rheumatology. 16 July 2024. doi: 10.1016/S2665-9913(24)00151-6. 
Santomauro DF, Hedley D, Sahin E, et al. The global burden of suicide mortality among people on the autism spectrum: A systematic review, meta-analysis, and extension of estimates from the Global Burden of Disease Study 2021. Psychiatry Research. 20 August 2024. doi: 10.1016/j.psychres.2024.116150.
GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 16 May 2024. doi: 10.1016/S0140-6736(24)00933-4.
GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 17 April 2024. doi: 10.1016/S0140-6736(24)00757-8.